Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 15Dermatologic 1

Conditions

Melanoma 36Neoplasm Metastasis 12Carcinoma, Renal Cell 11Carcinoma, Non-Small-Cell Lung 11Lung Neoplasms 10Colorectal Neoplasms 7Carcinoma, Hepatocellular 7Carcinoma, Merkel Cell 6Uterine Cervical Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Ovarian Neoplasms 5Carcinoma, Basal Cell 5Lymphoma, T-Cell, Cutaneous 4Lymphoma, T-Cell 4Endometrial Neoplasms 4Carcinoma, Transitional Cell 4Uveal Melanoma 3Triple Negative Breast Neoplasms 3Thyroid Neoplasms 3Small Cell Lung Carcinoma 3Sarcoma, Kaposi 3Prostatic Neoplasms 3Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Esophageal Neoplasms 3Carcinosarcoma 3Breast Neoplasms 3Stomach Neoplasms 2Skin Neoplasms 2Sarcoma 2

Interventions

Drug Therapy 2pembrolizumab 1motexafin gadolinium 1cobimetinib 1cabozantinib 1Vemurafenib 1Specimen Handling 1Ritonavir 1Radiotherapy 1Quality of Life 1Patient Reported Outcome Measures 1Observation 1Nivolumab 1Molecular Diagnostic Techniques 1Magnetic Resonance Spectroscopy 1Indinavir 1Immunotherapy 1Doxorubicin 1Biopsy 1Biological Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Laryngeal Neoplasms × Specimen Handling × Dermatologic × Clear all
NCT05136196 2026-06-05

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

National Cancer Institute (NCI)

Phase 2 Recruiting
150 enrolled
DermatologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Melanoma, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡